デフォルト表紙
市場調査レポート
商品コード
1448308

左心房付属器閉鎖装置の世界市場規模、シェア、成長分析:製品別、手術別、最終用途別 - 産業予測(2024年~2031年)

Global Left Atrial Appendage Closure Devices Market Size, Share, Growth Analysis, By Product, By Procedure, By End - Use - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
左心房付属器閉鎖装置の世界市場規模、シェア、成長分析:製品別、手術別、最終用途別 - 産業予測(2024年~2031年)
出版日: 2024年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の左心房付属器閉鎖装置の市場規模は、2022年に12億1,000万米ドルとなり、2023年の14億6,000万米ドルから2031年には64億8,000万米ドルに拡大し、予測期間中(2024年~2031年)にCAGR20.5%で成長すると予測されています。

心臓疾患の一つである心房細動の症例数の増加は、不健康な食生活、喫煙、運動不足などに関連しています。このような治療需要の増加は、生活様式の変化、ヘルスケアへのアクセスの容易さ、心臓疾患のリスクを抱える高齢者の増加にも影響されています。また、心臓のリズムに関連した手術に高度な技術を用いる機会も増えており、安全性と有効性が向上し、先進国と発展途上国の両方に恩恵をもたらしています。

目次

エグゼクティブサマリー

  • 市場概要
  • 転変

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

左心房付属器閉鎖装置の世界市場:製品別

  • 市場概要
  • 心内膜LAA装置
  • 心外膜LAA装置

左心房付属器閉鎖装置の世界市場:手術別

  • 市場概要
  • 経皮的
  • 外科的

左心房付属器閉鎖装置の世界市場:最終用途別

  • 市場概要
  • 病院
  • 外来手術センター
  • その他

左心房付属器閉鎖装置の世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主要市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • Boston Scientific Corporation(USA)
  • Abbott Laboratories(USA)
  • AtriCure, Inc.(USA)
  • Johnson & Johnson(USA)
  • Lifetech Scientific(China)
  • Occlutech International AB(Sweden)
  • Artio Medical(USA)
  • Cardia, Inc.(USA)
  • SentreHEART, Inc.(USA)
  • Lepu Medical Technology Co., Ltd.(China)
目次
Product Code: SQMIG35A2586

Global Left Atrial Appendage Closure Devices Market size was valued at USD 1.21 billion in 2022 and is poised to grow from USD 1.46 billion in 2023 to USD 6.48 billion by 2031, growing at a CAGR of 20.5% in the forecast period (2024-2031).

The rise in cases of atrial fibrillation, a heart condition, is connected to things like unhealthy diets, smoking, and lack of exercise. This increase in demand for treatment is also influenced by changes in how we live, easier access to healthcare, and more older people who are at risk of heart problems. There's also a growing opportunity in using advanced technology for procedures related to heart rhythm, which has improved safety and effectiveness, benefiting both developed and developing countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Left Atrial Appendage Closure Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Left Atrial Appendage Closure Devices Market Segmental Analysis

The global left atrial appendage closure devices market is segmented on the basis of product, procedure, end use, and region. By product, the market is segmented into endocardial LAA devices, epicardial LAA devices. By procedure, the market is segmented into percutaneous, surgical. By end - use, the market is segmented into hospitals, ambulatory surgical centers, and others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Left Atrial Appendage Closure Devices Market

The rising number of people with atrial fibrillation, which increases the risk of stroke and heart problems, is a big reason why more left atrial appendage (LAA) closure devices are being used.

Restraints in the Global Left Atrial Appendage Closure Devices Market

Strict regulations for approving medical devices can delay the release of new products and restrict access to LAA closure devices in some markets.

Market Trends of the Global Left Atrial Appendage Closure Devices Market

The move toward less invasive treatments is causing a shift away from open-heart surgeries to minimally invasive procedures for closing the left atrial appendage (LAA). This change means patients have shorter recovery times and spend less time in the hospital.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Left Atrial Appendage Closure Devices Market by Product

  • Market Overview
  • Endocardial LAA Devices
  • Epicardial LAA Devices

Global Left Atrial Appendage Closure Devices Market by Procedure

  • Market Overview
  • Percutaneous
  • Surgical

Global Left Atrial Appendage Closure Devices Market by End - Use

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Global Left Atrial Appendage Closure Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AtriCure, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifetech Scientific (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Occlutech International AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artio Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardia, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SentreHEART, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments